The novel therapy of this peptide represents a significant development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – leading to enhanced blood sugar control and anticipated w